Radionuclide Diagnosis of Breast Cancers

Abstract:

To study the diagnostic capabilities of planar breast scintigraphy and single photon emission computed tomography (SPECT) with ^99mTc-MIBI in visualizing of breast tumors, 61 patients with a diagnosis of breast cancer were included in the study. The results showed that sensitivity of the planar mode in identifying primary breast tumors was 46%. The sensitivity of SPECT in detecting primary tumor was 93.4%. The sensitivity of the planar mode in visualization of nodal metastases was 44.8%, against 93.1% in SPECT. This study showed that SPECT has a high diagnostic efficiency in regard of visualization of small sized tumors, multicenter tumor growth, identifying space-occupying lesions on the background of modified breast tissue.

• Periodical: Advanced Materials Research (Volume 1084)
• Pages: 460-463
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.1084.460
• Online since: January 2015
• Authors: Anna Titskaya, Vladimir Chernov, Elena Slonimskaya, Ivan Sinilkin, Roman Zelchan*
• Keywords: Breast Cancer, Breast Scintigraphy, Planar Mode Tomography, Sensitivity

References

[1] V.D. Zavadovskaya, A.P. Kurazhov, O. Yu. Kilina, M.A. Zorkal'tsev, E.L. Choinzonov, V.I. Chernov, E.M. Slonimskaya, A.V. Bogoutdinova, I.I. Anisenya, F.F. Titskaya, R.V. Zelchan, 199tl-chloride scintigraphy: different types of visualization of musculoskeletal malignant tumors, Diagnostic and Interventional Radiology 7(1) (2013).

DOI: 10.20538/1682-0363-2012-3-120-131

[2] B.R. Mittal, R.K. Singh, S. Kumari, K. Manohar, A. Bhattacharya, G. Singh, Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer Indian J. Nucl. Med. 27(4) (2012).

DOI: 10.4103/0972-3919.115391

[3] K.R. Zasadny, M. Tatsumi, R.L. Wahl, FDG metabolism and uptake versus blood flow in women with untreated primary breast cancer, Eur. J. Nuc. Med. And Molecular Imaging. 30(2) (2003) 274-279.

DOI: 10.1007/s00259-002-1022-z

[4] V.I. Chernov, R.V. Zel'chan, A.A. Titskaya, I.G. Sinilkin, Gamma scintigraphy with 99m Tc-MIBI in the complex diagnostics and assessment of neoadjuvant chemotherapy efficacy in laryngeal and laryngopharyngeal cancer, Medical Radiology and Radiation Safety 56(2) (2011).

[5] M. Agrawal, J. Abraham, F.M. Balis, M. Edgerly, W.D. Stein, Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576, Clin. Cancer. Res. 9(2) (2003) 650-656.

[6] C.M. Gomes, M.F. Botelho, A. Abrunhosa, Uptake and efflux kinetics of Tc-99m MIBI and Tc-99m tetrafosmin in a Pgp-expressing tumour cell line, Eur. J. Nuc. Med. 31(2) (2003) 275.

[7] L. Kabasakal, M. Halaĉ, C. Nisli, O. Oguz, C. Onsel, et al. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi, J. Clin. Nucl. Med. 25(1) (2000) 20-23.

DOI: 10.1097/00003072-200001000-00005

[8] R. Danielsson, A. Sanchez-Crespo, A. Pegerfalk, 99mTc-sestamibi uptake and histological malignancy grade in invasise breast carcinoma. Eur. Jur. Nuc. Med. 30(5) (2003) 662-666.

DOI: 10.1007/s00259-003-1132-2

[9] L. Mansi, P.F. Rambaldi, E. Procaccini, Scintimammography with Technetium-99m tetrafosmin in the diagnosis of breast cancer and lymph node metastasis. Eur. J. Nuc. Med. 23 (1996) 932-939.

DOI: 10.1007/bf01084367

[10] S.V. Kanaev, S.N. Novikov, P.V. Krivorot'ko, V.F. Semiglazov, P.I. Kryzhevitskii, Interpretation of breast imaging with 99mTc-MIBI by semiquantitative lesion characterization, Problems in Oncology 58(6) (2012) 768-772 (Russian).

[11] S.J. Kim, Y.T. Bae, J.S. Lee, I.J. Kim, Y.K. Kim, Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings: visual and quantitative analyses, J. Ann. Nucl. Med. 21(3) (2007) 145-150.

DOI: 10.1007/s12149-006-0002-y

[12] W. Yu. Ussov, J.E. Riannel, J.M. Michailovic, Quantification of breast cancer blood flow in absolute units using Rutland-Patlak analysis of 99mTc MIBI uptake, Reviews in Nucl. Med. Countries of Central and east Europe 2(2) (1999) 36-44.

[11] F. Scopinaro, O. Schillaci, M. Scarpini, Technetium-99m sestamibi: an indicator of breast cancer invasiveness, Eur. J. Nuc. Med. 21(9) (1994) 984-987.

DOI: 10.1007/bf00238124

[12] A. Spanu, O. Schillaci, G.B. Meloni, The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas, In. t J. Oncol. 21(4) (2002) 831-40.

DOI: 10.3892/ijo.21.4.831